Hikma Pharmaceuticals (HKMPF) Short Interest Ratio & Short Volume → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free HKMPF Stock Alerts $24.50 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest Hikma Pharmaceuticals Short Interest DataCurrent Short Volume1,741,900 sharesPrevious Short Volume1,742,100 sharesChange Vs. Previous Month-0.01%Dollar Volume Sold Short$42.24 millionShort Interest Ratio / Days to Cover5,806.3Last Record DateApril 15, 2024Outstanding Shares220,230,000 sharesPercentage of Shares Shorted0.79%Today's Trading Volume0 sharesAverage Trading Volume68 sharesToday's Volume Vs. Average0% Short Selling Hikma Pharmaceuticals ? Sign up to receive the latest short interest report for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHKMPF Short Interest Over TimeHKMPF Days to Cover Over TimeHKMPF Percentage of Float Shorted Over Time Ad American Hartford Gold GroupTrump Asset Seizure Threat Alert: Could Your Savings Be Next?Trump Asset Seizures Threat A Warning For 401K Owners?Request Your FREE WEALTH PROTECTION GUIDE Hikma Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,741,900 shares $42.24 million 0.0%N/A5806.3 $24.25 3/31/20241,742,100 shares $40.71 million +0.2%N/A8710.5 $23.37 3/15/20241,739,000 shares $40.64 million 0.0%N/A8695 $23.37 2/29/20241,739,100 shares $46.09 million +0.1%N/A5797 $26.50 2/15/20241,737,700 shares $43.44 million -1.2%N/A2172.1 $25.00 1/15/20241,756,000 shares $43.30 million No ChangeN/A8780 $24.66 Get the Latest News and Ratings for HKMPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,756,000 shares $40.01 million -10.0%N/A2676.8 $22.79 12/15/20231,951,100 shares $43.02 million +0.1%N/A19511 $22.05 11/30/20231,948,900 shares $42.95 million +0.3%N/A721.8 $22.04 11/15/20231,944,100 shares $43.28 million +0.5%N/A4860.3 $22.26 10/31/20231,934,300 shares $45.24 million +4.5%N/A4835.8 $23.39 10/15/20231,850,400 shares $46.97 million +5.5%N/A9252 $25.38 9/30/20231,754,100 shares $47.36 million -1.1%N/A17541 $27.00 9/15/20231,774,300 shares $47.91 million -0.1%N/A17743 $27.00 8/31/20231,775,300 shares $47.93 million +0.1%N/A1894.6 $27.00 8/15/20231,774,500 shares $46.94 million +0.1%N/A4436.3 $26.45 7/31/20231,773,300 shares $46.90 million +13.1%N/A479.3 $26.45 7/15/20231,567,500 shares $36.24 million 0.0%N/A1045 $23.12 6/30/20231,567,700 shares $36.21 million -8.0%N/A7838.5 $23.10 6/15/20231,703,900 shares $40.89 million +0.4%N/A8519.5 $24.00 5/31/20231,697,100 shares $39.03 million -0.3%N/A5657 $23.00 5/15/20231,702,000 shares $38.96 million -0.7%N/A17020 $22.89 4/30/20231,714,200 shares $39.72 million +0.4%N/A2857 $23.17 4/15/20231,707,400 shares $35.24 million +11.9%N/A17074 $20.64 3/31/20231,526,500 shares $30.94 million -2.7%N/A1908.1 $20.27 3/15/20231,569,000 shares $32.38 million -0.2%N/A2241.4 $20.64 2/28/20231,571,400 shares $33.20 million +0.3%N/A3928.5 $21.13 2/15/20231,567,000 shares $32.67 million -0.9%N/A3134 $20.85 1/31/20231,580,400 shares $29.82 million +0.6%N/A0 $18.87 1/15/20231,571,500 shares $29.65 million -0.6%N/A0 $18.87 12/30/20221,581,500 shares $29.84 million +0.0%N/A3953.8 $18.87 12/15/20221,581,200 shares $29.84 million -0.1%N/A15812 $18.87 11/30/20221,582,800 shares $22.62 million -0.3%N/A3165.6 $14.29 11/15/20221,588,000 shares $22.69 million +0.3%N/A15880 $14.29 10/31/20221,582,900 shares $22.62 million +0.2%N/A3165.8 $14.29 10/15/20221,579,400 shares $22.55 million +0.4%N/A493.6 $14.28 9/30/20221,572,800 shares $21.64 million +0.2%N/A1966 $13.76 9/15/20221,569,100 shares $23.32 million +114.5%N/A412.9 $14.86 8/31/2022731,700 shares $10.87 million No ChangeN/A385.1 $14.86 8/15/2022731,700 shares $14.20 million +0.5%N/A7317 $19.41Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 HKMPF Short Interest - Frequently Asked Questions What is Hikma Pharmaceuticals' current short interest? Short interest is the volume of Hikma Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,741,900 shares of HKMPF short. Learn More on Hikma Pharmaceuticals' current short interest. What is a good short interest ratio for Hikma Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HKMPF shares currently have a short interest ratio of 5,806.0. Learn More on Hikma Pharmaceuticals's short interest ratio. Is Hikma Pharmaceuticals' short interest increasing or decreasing? Hikma Pharmaceuticals saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 1,741,900 shares, a decline of 0.0% from the previous total of 1,742,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Hikma Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Hikma Pharmaceuticals: Orion Oyj (0.00%), Zealand Pharma A/S (0.80%), Aspen Pharmacare Holdings Limited (0.00%), GN Store Nord A/S (0.00%), Sino Biopharmaceutical Limited (0.08%), Amplifon S.p.A. (1.34%), Nihon Kohden Co. (0.00%), Ramsay Health Care Limited (0.00%), Sonic Healthcare Limited (0.00%), Sysmex Co. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Hikma Pharmaceuticals stock? Short selling HKMPF is an investing strategy that aims to generate trading profit from Hikma Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hikma Pharmaceuticals? A short squeeze for Hikma Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HKMPF, which in turn drives the price of the stock up even further. How often is Hikma Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HKMPF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ORINY Short Squeeze ZLDPF Short Squeeze APNHY Short Squeeze GNNDY Short Squeeze SBMFF Short Squeeze AMFPF Short Squeeze NHNKY Short Squeeze RMYHY Short Squeeze SKHHY Short Squeeze SSMXY Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HKMPF) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupUrgent Nvidia WarningAltimetry